What to do if standard therapy for hepatitis C fails
What to do if standard therapy for hepatitis C fails
The standard of care for treatment of individuals chronically infected with hepatitis C virus is pegylated interferon in combination with ribavirin. Efficacy is closely related to viral genotype. This review outlines potential therapeutic strategies for treatment failures and discusses some of the newer agents currently in development.
1-41
Tanwar, S.
4c087a17-47bc-4a07-9f0b-0550b2c14e1f
Khakoo, Salim I.
6c16d2f5-ae80-4d9b-9100-6bfb34ad0273
28 May 2009
Tanwar, S.
4c087a17-47bc-4a07-9f0b-0550b2c14e1f
Khakoo, Salim I.
6c16d2f5-ae80-4d9b-9100-6bfb34ad0273
Tanwar, S. and Khakoo, Salim I.
(2009)
What to do if standard therapy for hepatitis C fails.
F1000 Medicine Reports, 1 (M141), .
(doi:10.3410/M1-41).
Abstract
The standard of care for treatment of individuals chronically infected with hepatitis C virus is pegylated interferon in combination with ribavirin. Efficacy is closely related to viral genotype. This review outlines potential therapeutic strategies for treatment failures and discusses some of the newer agents currently in development.
This record has no associated files available for download.
More information
Published date: 28 May 2009
Organisations:
Clinical & Experimental Sciences
Identifiers
Local EPrints ID: 337807
URI: http://eprints.soton.ac.uk/id/eprint/337807
ISSN: 1757-5931
PURE UUID: c7047304-e4a8-4733-82fe-5d2b236c444f
Catalogue record
Date deposited: 03 May 2012 15:13
Last modified: 15 Mar 2024 03:12
Export record
Altmetrics
Contributors
Author:
S. Tanwar
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
